Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors
Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. A descriptive study using an...
Uložené v:
| Vydané v: | Medical decision making Ročník 39; číslo 7; s. 805 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.10.2019
|
| Predmet: | |
| ISSN: | 1552-681X, 1552-681X |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials.
A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use.
Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation (
= 29; 28%), dissemination to target user(s) (
= 9; 9%), and diffusion (
= 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process.
Self-report bias and potential for recall bias.
Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use. |
|---|---|
| AbstractList | Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. Design. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Results. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation (n = 29; 28%), dissemination to target user(s) (n = 9; 9%), and diffusion (n = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Limitations. Self-report bias and potential for recall bias. Conclusions. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use.Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. Design. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Results. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation (n = 29; 28%), dissemination to target user(s) (n = 9; 9%), and diffusion (n = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Limitations. Self-report bias and potential for recall bias. Conclusions. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our study aimed to determine subsequent PtDA use in clinical practice following published randomized controlled trials. A descriptive study using an e-mail-embedded questionnaire survey targeting authors of 133 trials included in Cochrane Reviews of PtDAs (106 authors). We classified PtDA level of use as a) implementation, defined as integrating within care processes; b) dissemination to target users with planned strategies; and c) diffusion, defined as passive, unplanned spread. We conducted content analysis to identify barriers and enablers guided by the Ottawa Model of Research Use. Ninety-eight authors responded (92.5%) on 108 trialed PtDAs. Reported levels of use were implementation ( = 29; 28%), dissemination to target user(s) ( = 9; 9%), and diffusion ( = 7; 7%); 57 (55%) reported no uptake, and 1 had no response (1%). Barriers to use in clinical practice were identified at the level of researchers (e.g., lack of posttrial plan), PtDAs (e.g., outdated, delivery mechanism), clinicians (e.g., disagreed with PtDA use), and practice environment (e.g., infrastructure support; funding). Enablers were online delivery, organizational endorsement (e.g., professional organization, charity, government), and design for and integration into the care process. Self-report bias and potential for recall bias. Only 44% of PtDA trial authors indicated some level of subsequent use following their trial. The most commonly reported barriers were lack of funding, outdated PtDAs, and clinician disagreement with PtDA use. To improve subsequent use, researchers should codesign PtDAs with end users to ensure fit with clinical practice and develop an implementation plan. National systems (e.g., platforms, endorsement, funding) can enable use. |
| Author | Suwalska, Victoria Presseau, Justin Thomson, Richard Stacey, Dawn Boland, Laura Lewis, Krystina B |
| Author_xml | – sequence: 1 givenname: Dawn orcidid: 0000-0002-2681-741X surname: Stacey fullname: Stacey, Dawn organization: University of Ottawa, Ottawa, ON, Canada – sequence: 2 givenname: Victoria surname: Suwalska fullname: Suwalska, Victoria organization: University of Ottawa, Ottawa, ON, Canada – sequence: 3 givenname: Laura orcidid: 0000-0001-8680-9844 surname: Boland fullname: Boland, Laura organization: University of Ottawa, Ottawa, ON, Canada – sequence: 4 givenname: Krystina B orcidid: 0000-0001-6761-7548 surname: Lewis fullname: Lewis, Krystina B organization: University of Ottawa, Ottawa, ON, Canada – sequence: 5 givenname: Justin surname: Presseau fullname: Presseau, Justin organization: University of Ottawa, Ottawa, ON, Canada – sequence: 6 givenname: Richard surname: Thomson fullname: Thomson, Richard organization: Institute of Health and Society, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31423911$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUEtLAzEYDFKxD717khy9rCbZR5KTLLU-oGDRFnor2c0XG9kmNdkt9N-7YAVPMwMzwzBjNHDeAULXlNxRyvk9YZxJIddUikJQmZ6hEc1zlvRiPfjHh2gc4xchNJMiu0DDlGYslZSO0LYMgBeqteBa_Ai1jdY7XFod8SqCxtbhaWOdrVWDF0HVra0BK9NCwO_20wffRTw7qKbrK7x7wCX-6MIBjtgbvAy2T5Vdu_UhXqJzo5oIVyecoNXTbDl9SeZvz6_Tcp7UacrbROSVYJUmIAjRolJGaiOlyUyVmkKYTBQGFBMV54RyojnhhdRCS0nyQhGRsgm6_e3dB__dQWw3OxtraBrloB-7YYznMutPYb315mTtqh3ozT7YnQrHzd877AeXIWhm |
| CitedBy_id | crossref_primary_10_1016_j_cct_2022_106940 crossref_primary_10_1186_s12888_020_02845_0 crossref_primary_10_1016_j_pecinn_2024_100269 crossref_primary_10_1016_j_pecinn_2025_100425 crossref_primary_10_1186_s12911_021_01468_z crossref_primary_10_1111_jgs_16371 crossref_primary_10_1186_s12882_020_01956_w crossref_primary_10_1038_s41572_025_00637_y crossref_primary_10_1186_s12911_023_02186_4 crossref_primary_10_1016_j_rcsop_2021_100039 crossref_primary_10_1016_j_pecinn_2024_100300 crossref_primary_10_1186_s12875_023_02179_2 crossref_primary_10_1016_j_rmed_2021_106568 crossref_primary_10_1186_s12911_020_01251_6 crossref_primary_10_1007_s11606_024_08656_3 crossref_primary_10_3390_genes16040423 crossref_primary_10_1186_s12905_024_03172_2 crossref_primary_10_1016_j_pec_2021_10_026 crossref_primary_10_1080_02687038_2022_2039588 crossref_primary_10_1186_s12911_025_03044_1 crossref_primary_10_1016_j_euo_2024_09_003 crossref_primary_10_1371_journal_pone_0300944 crossref_primary_10_1016_j_pec_2023_107652 crossref_primary_10_1177_0272989X20979693 crossref_primary_10_1186_s12911_025_03084_7 crossref_primary_10_1016_j_jpurol_2022_09_015 crossref_primary_10_1016_j_pec_2022_11_003 crossref_primary_10_1159_000536296 crossref_primary_10_1177_0272989X20978208 crossref_primary_10_1111_nuf_12840 crossref_primary_10_2196_57611 crossref_primary_10_1002_cncr_32959 crossref_primary_10_1016_j_jclinepi_2024_111509 crossref_primary_10_1016_j_jadohealth_2022_10_022 crossref_primary_10_9778_cmajo_20220224 crossref_primary_10_2196_69756 crossref_primary_10_1016_j_pec_2024_108418 crossref_primary_10_1007_s11606_023_08597_3 crossref_primary_10_1186_s12911_023_02259_4 crossref_primary_10_1002_jhm_13475 crossref_primary_10_1016_j_pec_2024_108484 crossref_primary_10_1108_ADD_10_2022_0028 crossref_primary_10_1007_s00198_020_05479_w crossref_primary_10_1186_s12911_022_02056_5 crossref_primary_10_1371_journal_pone_0259844 crossref_primary_10_3389_fonc_2022_896939 crossref_primary_10_1108_JSM_11_2023_0408 crossref_primary_10_1007_s00415_025_12972_x crossref_primary_10_1136_bmjopen_2020_037575 crossref_primary_10_1177_0272989X231205858 crossref_primary_10_1016_j_pec_2023_108096 crossref_primary_10_1002_14651858_CD001431_pub6 crossref_primary_10_1093_eurjcn_zvad138 crossref_primary_10_3390_cancers16071390 crossref_primary_10_1016_j_jclinepi_2025_111708 crossref_primary_10_1093_ejendo_lvae050 crossref_primary_10_1001_jamainternmed_2020_0440 crossref_primary_10_1186_s12911_022_01777_x crossref_primary_10_1177_0272989X251368866 crossref_primary_10_1016_j_fjurol_2025_102868 crossref_primary_10_1177_0272989X211014163 crossref_primary_10_1093_jamiaopen_ooae079 crossref_primary_10_1136_bmjopen_2021_057293 crossref_primary_10_1186_s40900_022_00354_w |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/0272989X19868193 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1552-681X |
| ExternalDocumentID | 31423911 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: CIHR |
| GroupedDBID | --- -TM .2G .2J .2N .55 .GJ 01A 0R~ 123 18M 1~K 29M 31S 31U 31X 31Y 31Z 39C 4.4 53G 54M 5RE 5VS AABMB AABOD AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAJIQ AAJOX AAJPV AAMGE AANEX AANSI AAPEO AAQDB AAQQT AAQXH AAQXI AARDL AARIX AATAA AATBZ AAWTL AAYTG ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABHQH ABIVO ABJIS ABJNI ABKRH ABLUO ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACGBL ACGFO ACGFS ACGOD ACGZU ACJER ACLHI ACLZU ACMJI ACOFE ACOXC ACROE ACRPL ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADNMO ADNON ADRRZ ADTBJ ADUKL ADVBO ADYCS AECGH AECVZ AEDTQ AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXNY AFEET AFKBI AFKRG AFMOU AFQAA AFUIA AFWMB AGKLV AGNHF AGWFA AGWNL AHBZF AHDMH AHHFK AHMBA AIIQI AIOMO AJEFB AJMMQ AJUZI AJXAJ ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU ARTOV ASPBG AUTPY AUVAJ AVWKF AWUYY AYAKG AZFZN B3H B8O B8R B8Z B93 B94 BBRGL BDDNI BKIIM BPACV BSEHC BYIEH C45 CAG CBRKF CFDXU CGR COF CORYS CQQTX CS3 CUY CVF DC- DC. DD- DD0 DE- DF. DF0 DO- DOPDO DV7 D~Y EBS ECM EIF EIHBH EJD F5P FEDTE FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HVGLF HZ~ IAO IEA IH2 IHR INH INR IVC J8X K.F K.J M4V N9A NPM O9- OVD P.B P2P PQQKQ Q1R Q7K Q7L Q7X Q82 Q83 RIG ROL RWL RXW S01 SAUOL SBI SCNPE SDB SFB SFC SFH SFK SFT SGA SGP SGR SGV SGX SGZ SHG SNB SPJ SPP SPV SQCSI STM TAE TEORI TN5 X7M ZGI ZONMY ZPPRI ZRKOI ZXP 7X8 AAPII ABIDT ADDLC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c337t-85b82bd0e800d8baf9df99f4fb3f68f486fea28b770170d70769d8d99056a0832 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 73 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000483236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1552-681X |
| IngestDate | Sun Sep 28 07:12:55 EDT 2025 Wed Feb 19 02:31:02 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | dissemination health care implementation science patient decision aid |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c337t-85b82bd0e800d8baf9df99f4fb3f68f486fea28b770170d70769d8d99056a0832 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-6761-7548 0000-0002-2681-741X 0000-0001-8680-9844 |
| PMID | 31423911 |
| PQID | 2275946812 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2275946812 pubmed_primary_31423911 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-10-00 20191001 |
| PublicationDateYYYYMMDD | 2019-10-01 |
| PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Medical decision making |
| PublicationTitleAlternate | Med Decis Making |
| PublicationYear | 2019 |
| SSID | ssj0014984 |
| Score | 2.5231705 |
| Snippet | Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in practice. Our... Background. Patient decision aids (PtDAs) are effective interventions to support patient involvement in health care decisions, but there is little use in... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 805 |
| SubjectTerms | Decision Support Techniques General Practice - statistics & numerical data Humans Information Dissemination Patient Education as Topic - economics Patient Education as Topic - methods Patient Education as Topic - statistics & numerical data Patient Participation Randomized Controlled Trials as Topic |
| Title | Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31423911 https://www.proquest.com/docview/2275946812 |
| Volume | 39 |
| WOSCitedRecordID | wos000483236600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwGA3qRHzxfpk3PsHXsN6TPo2iDh_cKLpB30bTJFqQdrbbwH9v0mbuSRB86UsJbZOvyfm-k5yD0F3gWJxkKjvhluDYsz0fU4-5mHiBk3HXElQ2riXPZDSiSRLGpuBWm22Vqzmxmah5mekaec9xiB96Wi2rP_vE2jVKs6vGQmMTdVwFZXRUk2TNInhh4zisVcawapmsacqeysa09niicm51R9POvwHMZqEZ7P_3FQ_QnoGYELUxcYg2RHGEdoaGRD9G71ElIG71VOHBeOxAlPMaJrXgkBdg1EI_IDaHqKDxEoeX_K2sykUNjz8i4X2I4HVRLcUXlBLGOp5B193Kqj5Bk8Hj-P4JG8MFnLkumWPqM-owNWoKRXLKUhlyGYbSk8yVAZUeDaRIHcoI0ao7nFgkCDnlakHzg1RhOecUbRVlIc4REG4xh5FU-lRlOFZKNT-o4aTKYGzmB110u-rDqQpozVKkhVAfMF33YhedtQMxnbXKG1PX1nqFtn3xh9aXaFc_sN14d4U6Uv3O4hptZ8t5Xlc3TaSo6ygefgOuC8Yj |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+Patient+Decision+Aids+Used+in+Clinical+Practice+after+Rigorous+Evaluation%3F+A+Survey+of+Trial+Authors&rft.jtitle=Medical+decision+making&rft.au=Stacey%2C+Dawn&rft.au=Suwalska%2C+Victoria&rft.au=Boland%2C+Laura&rft.au=Lewis%2C+Krystina+B&rft.date=2019-10-01&rft.issn=1552-681X&rft.eissn=1552-681X&rft.volume=39&rft.issue=7&rft.spage=805&rft_id=info:doi/10.1177%2F0272989X19868193&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-681X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-681X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-681X&client=summon |